AKT2 and Insulin resistance: Furthermore, knockdown or mutations of Akt2/PKBβ resulted into severe insulin resistance and altered glycemia, probably because defects of this important mediator lead to a reduction of AS160-induced GLUT4 translocation in both mice [31] and humans [32].